Piramal Pharma shares hit 52-week high post Q4
In the January to March quarter of FY24, Piramal Pharma’s revenue from operations grew 18% to ₹2,552 crore as against ₹2,164 crore in the corresponding period of the previous year.
piramal pharma
May 2024
April 2024
October 2023
October 2022
.JPG?rect=0,0,1250,625&w=300&q=95)
Contract Manufacturing: Pharma’s New Growth Pill
Domestic contract development and manufacturing organisations are raking it in, thanks to India’s emergence as a pharma R&D hub and China’s supply chain issues.
Piramal Pharma shares rise 8% after Q2 results
The company reported a consolidated net profit of ₹5 crore in the July to September quarter of FY24. The company had reported a loss of ₹37 crore in the same period last year.
Ajay Piramal begins 2nd innings in pharma
Lists Piramal Pharma Ltd (PPL) on stock exchanges, with 35% stake with Piramal family and 20% with Carlyle Group.
Piramal Pharma hits 5% lower circuit on listing
Shares of Piramal Pharma opened at ₹201.80 on the BSE, while it declined 5% to hit a lower circuit of ₹191.75.
